Welcome to eBioscience   Tel: 888.999.1371 or 858.642.2058
Fax: 858.642.2046
Web: www.ebioscience.com
E-mail: info@ebioscience.com

Product Information


Contents: Biotin anti-human DcR2 (CD264, TRAIL-R4, TRAILR4, TRUNDD, TNFRSF10D)
Catalog Number: 13-6239
Formulation: Phosphate buffer pH 7.2,
150 mM NaCl, 0.09% NaN3
Storage Conditions: Store at 4°C.
DO NOT FREEZE.
Clone: DJR4-1
Isotype: Mouse IgG1, κ
 
 
data image 1
Surface staining of human DcR2 transfected cells with anti-human DcR2 (DJR4-1) PE. Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis. 

Available Formats of This Product
Cat. No. Format Excite
(nm)
Emit
(nm)
Reported Applications

Custom Product Requests
Need a custom product? Download the Custom Product Request Form and submit completed form to customs@ebioscience.com.

Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq.

Description


The DJR4-1 monoclonal antibody reacts with human Decoy receptor 2 (DcR2), a transmembrane cell surface protein also known as TRAIL-R4 and TRUNDD. DcR2 has an extracellular TRAIL binding domain and a truncation in the death domain (DD) of its cytoplasmic tail. Along with DcR1, DcR2 binds to TRAIL and inhibits binding of TRAIL to DR4 or DR5 protecting cells from TRAIL-mediated cytotoxicity. DcR2 is expressed in many normal human tissues at low levels, but not in most tumors. Overexpression of DcR2 attenuates TRAIL-induced apoptosis.


Applications Reported


For research use only, not for diagnostic or therapeutic use. The DJR4-1 antibody has been reported for use in flow cytometric analysis.


Applications Tested


The DJR4-1 antibody has been tested by flow cytometric analysis of DcR2/293 transient transfected cells. This can be used at less than or equal to 1 μg per million cells in a 100 μl total staining volume. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest.


References


Gomez-Benito M, Martinez-Lorenzo MJ et al. 2007. Membrane expression of DR4, DR5 and caspase-8 levels, but not Mcl-1, determine sensitivity of human myeloma cells to Apo2L/TRAIL. Exp Cell Res. 2007 Jul 1;313(11):2378-88. (FC, PubMed)

Mulherkar N, Prasad KV et al. 2007. MADD/DENN splice variant of the IG20 gene is a negative regulator of caspase-8 activation. Knockdown enhances TRAIL-induced apoptosis of cancer cells. J Biol Chem. 2007 Apr 20;282(16):11715-21. (FC, PubMed)


Related Products


Cat. 11-4317  Streptavidin-FITC (Fluorescein isothiocyanate)
Cat. 12-4317  Streptavidin-PE (Phycoerythrin)
Cat. 17-4317  Streptavidin Allophycocyanin (SA-APC)
Cat. 13-4714  Biotin Mouse IgG1, K Isotype Control



Copyright © 2000-2008 eBioscience, Inc.
For Research Use Only. Not for use in diagnostic procedures. Not for further distribution without written consent.